NICE published a clinical guideline on the treatment and management of depression in adults with chronic physical health problems in 2009. This new evidence update refreshes that guidance by searching for new systematic reviews and randomised controlled trials on the subject and summarising them in a short (16 page) document. The authors searched a range [read the full story…]
We know that various psychotherapies are effective in treating adult depression, but there remains quite a bit of uncertainty about which specific therapies work best and what factors within the treatments contribute most to the improvement. This new meta analysis from a mixed group of researchers from the Netherlands, USA, Switzerland and Sweden, looks at [read the full story…]
Antipsychotic drugs are currently prescribed to a significant proportion of young people who are diagnosed with psychosis. Past research has estimated that up to half of people at risk of developing psychosis at a young age will progress to a full blown psychotic illness such as schizophrenia. A new landmark randomised controlled trial has been [read the full story…]
Around 10% of children are diagnosed with anxiety disorders before the age of 16 and for many this can be a long lasting problem that has a major impact on their development. There’s lots of research in this field and many systematic reviews have been conducted to assess the effectiveness of talking treatments for this [read the full story…]
Depression is at least three times as common in patients with cancer compared to the rest of the population. Studies show that major depression occurs in 16% of cancer patients, with combined minor depression and dysthymia reported in 22% of people with cancer. Depression also appears to be more prevalent amongst people with certain cancers (pancreatic, [read the full story…]
For many different reasons, people with schizophrenia and schizoaffective disorders have a greater risk of type 2 diabetes. The prevalence of type 2 diabetes in people with schizophrenia is twice that of the general population. This review looked for evidence of the efficacy of interventions to help people with schizophrenia manage their diabetes. Clinical question [read the full story…]
Exercise is a good thing right? It seems obvious that people who are affected by mental health problems would benefit from getting themselves outside and becoming more active, but are these ‘treatments’ value for money when they are delivered in a structured way? The current NICE depression guideline recommends ‘structured’ physical activity programmes for depression [read the full story…]
People who take psychiatric drugs are well aware of the daily trade-off between the benefits and the harms of their medication. This is a key consideration for pregnant women with depression, who don’t just have to consider the side effects that may strike them, but also the impact they may have on their unborn child. [read the full story…]
There continues to be a considerable amount of debate about the amount of psychiatric medication that is prescribed and how much it costs. Statistics from a number of countries have shown that many classes of drugs are being prescribed more and more, including antidepressants, antipsychotics and stimulants. Of course, as populations grow, people live longer [read the full story…]
Young people with autism spectrum disorders (ASD) are usually given some kind of behavioural or educational intervention to help improve their overall functioning. However, in some cases, those individuals who have high levels of repetitive, obsessive-compulsive type behaviours and mood disorders are treated with drug interventions, although there is little high quality evidence to support [read the full story…]
